The present study supports the paradigm that lysosomal VRK2 serves as a functional regulator of autophagy via the recruitment of activated Akt to lysosomes to control the proper biogenesis of functional lysosomes, which could be a novel molecular target for cancer therapy [97] (Fig. 9). This evidence concerns the gene AKT1 and cancer.